Literature DB >> 8839690

Bioequivalence assessment of generic drugs: an American point of view.

R Patnaik1, L J Lesko, K Chan, R L Williams.   

Abstract

Mesh：

Substances：

Year:  1996        PMID： 8839690     DOI： 10.1007/BF03190265

Source DB:  PubMed          Journal:  Eur J Drug Metab Pharmacokinet        ISSN： 0378-7966            Impact factor:   2.441


× No keyword cloud information.
  14 in total

Review 1.  Bioequivalence of racemic drugs.

Authors:  S G Nerurkar; S V Dighe; R L Williams
Journal:  J Clin Pharmacol       Date:  1992-10       Impact factor: 3.126

2.  An alternative approach for assessment of rate of absorption in bioequivalence studies.

Authors:  M L Chen
Journal:  Pharm Res       Date:  1992-11       Impact factor: 4.200

3.  Comparison of absorption rates in bioequivalence studies of immediate release drug formulations.

Authors:  R Schall; H G Luus
Journal:  Int J Clin Pharmacol Ther Toxicol       Date:  1992-05

Review 4.  Controversies in bioequivalence studies.

Authors:  V W Steinijans; D Hauschke; J H Jonkman
Journal:  Clin Pharmacokinet       Date:  1992-04       Impact factor: 6.447

5.  Cmax/AUC is a clearer measure than Cmax for absorption rates in investigations of bioequivalence.

Authors:  L Endrenyi; S Fritsch; W Yan
Journal:  Int J Clin Pharmacol Ther Toxicol       Date:  1991-10

6.  A comparison of the two one-sided tests procedure and the power approach for assessing the equivalence of average bioavailability.

Authors:  D J Schuirmann
Journal:  J Pharmacokinet Biopharm       Date:  1987-12

7.  On population and individual bioequivalence.

Authors:  R Schall; H G Luus
Journal:  Stat Med       Date:  1993-06-30       Impact factor: 2.373

8.  Bioequivalence: performance of several measures of rate of absorption.

Authors:  F Y Bois; T N Tozer; W W Hauck; M L Chen; R Patnaik; R L Williams
Journal:  Pharm Res       Date:  1994-07       Impact factor: 4.200

9.  A new statistical procedure for testing equivalence in two-group comparative bioavailability trials.

Authors:  W W Hauck; S Anderson
Journal:  J Pharmacokinet Biopharm       Date:  1984-02

Review 10.  Clinical pharmacokinetic considerations in the elderly. An update.

Authors:  S Dawling; P Crome
Journal:  Clin Pharmacokinet       Date:  1989-10       Impact factor: 6.447
View more
  5 in total

Review 1.  Generic antiarrhythmic drugs: what constitutes equivalency.

Authors:  D G Benditt
Journal:  J Interv Card Electrophysiol       Date:  1999-07       Impact factor: 1.900

2.  Management of narrow therapeutic index drugs.

Authors:  M Burns
Journal:  J Thromb Thrombolysis       Date:  1999-04       Impact factor: 2.300

3.  Bioequivalence testing of a new tablet formulation of generic fluoxetine.

Authors:  D Jovanović; V Kilibarda; S Dordević; M Jovanović; J Jovic-Stosić; D Srdić; T Knezević
Journal:  Eur J Drug Metab Pharmacokinet       Date:  2006 Jan-Mar       Impact factor: 2.441

4.  Cubic spline functions and polynomials for calculation of absorption rate.

Authors:  J Popović
Journal:  Eur J Drug Metab Pharmacokinet       Date:  1998 Oct-Dec       Impact factor: 2.569

5.  Individualizing therapy - in search of approaches to maximize the benefit of drug treatment (II).

Authors:  Cornel Pater
Journal:  Curr Control Trials Cardiovasc Med       Date:  2004-08-16
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.